Opsoclonus associated with autoantibodies to glutamate receptors δ2

Affiliations

Case Reports

Takashi Hosaka et al. Neurol Sci. 2015 Sep.

. 2015 Sep;36(9):1741-2.

doi: 10.1007/s10072-015-2264-4. Epub 2015 May 26.

¹ Division of Clinical Medicine, Department of Neurology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, 305-8575, Japan.

No abstract available

Cited by

Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome.
Berridge G, Menassa DA, Moloney T, Waters PJ, Welding I, Thomsen S, Zuberi S, Fischer R, Aricescu AR, Pike M, Dale RC, Kessler B, Vincent A, Lim M, Irani SR, Lang B. Berridge G, et al. Neurology. 2018 Aug 21;91(8):e714-e723. doi: 10.1212/WNL.0000000000006035. Epub 2018 Jul 25. Neurology. 2018. PMID: 30045961 Free PMC article.
The low binding affinity of D-serine at the ionotropic glutamate receptor GluD2 can be attributed to the hinge region.
Tapken D, Steffensen TB, Leth R, Kristensen LB, Gerbola A, Gajhede M, Jørgensen FS, Olsen L, Kastrup JS. Tapken D, et al. Sci Rep. 2017 Apr 7;7:46145. doi: 10.1038/srep46145. Sci Rep. 2017. PMID: 28387240 Free PMC article.
The Successful Application of Plasmapheresis in the Treatment of a Patient with Opsoclonus and Autoantibodies to Glutamate Receptor δ2.
Nakamagoe K, Nohara S, Takahashi Y, Takiguchi M, Kawakami R, Koganezawa T, Tamaoka A. Nakamagoe K, et al. Intern Med. 2017 Oct 15;56(20):2773-2778. doi: 10.2169/internalmedicine.6771-15. Epub 2017 Sep 15. Intern Med. 2017. PMID: 28924105 Free PMC article.